REVELATION BIOSCIENCES, INC.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | $4.1M | $3.5M | $4.1M | $5.4M | $6.9M | — | — |
| SG&A Expense | — | $5.0M | $4.4M | $4.5M | $5.5M | $5.0M | $145.5K | — |
| Operating Income | — | $-9.1M | $-8.0M | $-8.7M | $-10.9M | $-12.0M | $-1.6M | — |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | — | — | — | — | — | $41.8K | — | — |
| Pretax Income | — | — | — | — | — | — | $-1.6M | — |
| Income Tax Expense | — | $0 | $0 | $0 | $0 | $0 | — | — |
| Net Income | — | $-8.9M | $-15.0M | $-120.3K | $-10.8M | $-12.0M | $-1.6M | $-3.6K |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | — | $-23.95 | $-24.47 | $-0.20 | $-3.47 | $-0.99 | $-0.02 | — |
| EPS (Diluted) | — | $-23.95 | $-24.47 | $-0.20 | $-3.47 | $-0.99 | $-0.02 | — |
| Shares Outstanding (Basic) | 3.7M | 620.8K | 614.6K | 612.6K | 3.1M | 12.1M | 103.6M | 78.2M |
| Shares Outstanding (Diluted) | 3.7M | 620.8K | 614.6K | 612.6K | 3.1M | 12.1M | 103.6M | 78.2M |
| Dividends Per Share | — | — | — | — | — | — | — | — |